148 related articles for article (PubMed ID: 19543507)
1. Non-association between polymorphisms of the frizzled receptor genes and bone mineral density in postmenopausal Korean women.
Kim JG; Kim H; Jee BC; Suh CS; Choi YM; Moon SY
J Korean Med Sci; 2009 Jun; 24(3):443-7. PubMed ID: 19543507
[TBL] [Abstract][Full Text] [Related]
2. Association between osteoprotegerin (OPG), receptor activator of nuclear factor-kappaB (RANK), and RANK ligand (RANKL) gene polymorphisms and circulating OPG, soluble RANKL levels, and bone mineral density in Korean postmenopausal women.
Kim JG; Kim JH; Kim JY; Ku SY; Jee BC; Suh CS; Kim SH; Choi YM
Menopause; 2007; 14(5):913-8. PubMed ID: 17667143
[TBL] [Abstract][Full Text] [Related]
3. Association between polymorphisms in leptin, leptin receptor, and β-adrenergic receptor genes and bone mineral density in postmenopausal Korean women.
Lee HJ; Kim H; Ku SY; Choi YM; Kim JH; Kim JG
Menopause; 2014 Jan; 21(1):67-73. PubMed ID: 23760429
[TBL] [Abstract][Full Text] [Related]
4. Cannabinoid receptor gene polymorphisms and bone mineral density in Korean postmenopausal women.
Woo JH; Kim H; Kim JH; Kim JG
Menopause; 2015 May; 22(5):512-9. PubMed ID: 25268406
[TBL] [Abstract][Full Text] [Related]
5. Changes in the serum levels of osteoprotegerin and soluble receptor activator for nuclear factor kappaB ligand after estrogen-progestogen therapy and their relationships with changes in bone mass in postmenopausal women.
Kim JG; Kim JH; Lee DO; Kim H; Kim JY; Suh CS; Kim SH; Choi YM
Menopause; 2008; 15(2):357-62. PubMed ID: 17925661
[TBL] [Abstract][Full Text] [Related]
6. Association of genetic polymorphisms of RANK, RANKL and OPG with bone mineral density in Chinese peri- and postmenopausal women.
Shang M; Lin L; Cui H
Clin Biochem; 2013 Oct; 46(15):1493-501. PubMed ID: 23531404
[TBL] [Abstract][Full Text] [Related]
7. Association of the A1330V and V667M polymorphisms of LRP5 with bone mineral density in Greek peri- and postmenopausal women.
Markatseli AE; Hatzi E; Bouba I; Georgiou I; Challa A; Tigas S; Tsatsoulis A
Maturitas; 2011 Oct; 70(2):188-93. PubMed ID: 21840657
[TBL] [Abstract][Full Text] [Related]
8. The influence of Lys3Asn polymorphism in the osteoprotegerin gene on bone mineral density in Chinese postmenopausal women.
Zhao HY; Liu JM; Ning G; Zhao YJ; Zhang LZ; Sun LH; Xu MY; Uitterlinden AG; Chen JL
Osteoporos Int; 2005 Dec; 16(12):1519-24. PubMed ID: 15782282
[TBL] [Abstract][Full Text] [Related]
9. Association between polymorphisms in period genes and bone density in postmenopausal Korean women.
Kim H; Koh H; Ku SY; Kim SH; Kim JH; Kim JG
Climacteric; 2014 Oct; 17(5):605-12. PubMed ID: 24678593
[TBL] [Abstract][Full Text] [Related]
10. Polymorphisms in period genes and bone response to hormone therapy in postmenopausal Korean women.
Kim J; Kim H; Ku SY; Suh CS; Kim JH; Kim JG
Climacteric; 2016; 19(1):85-90. PubMed ID: 26624862
[TBL] [Abstract][Full Text] [Related]
11. Association between polymorphisms in sclerostin, dickkopfs and secreted frizzled-related protein genes and bone mineral density in postmenopausal Korean women.
Lee DO; Kim H; Ku SY; Kim SH; Kim JG
Gynecol Obstet Invest; 2014; 77(3):186-93. PubMed ID: 24662300
[TBL] [Abstract][Full Text] [Related]
12. Association analyses of osteoprotegerin gene polymorphisms with bone mineral density in Chinese postmenopausal women.
Zhang F; He C; Chen G; Li F; Gao H
Med Oncol; 2013 Mar; 30(1):389. PubMed ID: 23335067
[TBL] [Abstract][Full Text] [Related]
13. Gene-gene interactions in RANK/RANKL/OPG system influence bone mineral density in postmenopausal women.
Zupan J; Mencej-Bedrac S; Jurković-Mlakar S; Prezelj J; Marc J
J Steroid Biochem Mol Biol; 2010 Jan; 118(1-2):102-6. PubMed ID: 19896533
[TBL] [Abstract][Full Text] [Related]
14. Implications of measuring soluble receptor activators of nuclear factor-kappaB ligand and osteoprotegerin in bone metabolism of elderly women.
Chiba Y; Onouchi T; Ikeda T; Adachi J; Tamura Y; Horiuchi T
Gerontology; 2009; 55(3):275-80. PubMed ID: 19158438
[TBL] [Abstract][Full Text] [Related]
15. Association between osteoprotegerin genetic variants and bone mineral density in Chinese women.
Shen L; Qiu Y; Xing S; Chen D; Zhu Y; He X; Wang J; Lai J; Shi G; Liao T; Tan J
Int Immunopharmacol; 2013 Jun; 16(2):275-8. PubMed ID: 23619553
[TBL] [Abstract][Full Text] [Related]
16. "Single nucleotide polymorphisms of the OPG/RANKL system genes in primary hyperparathyroidism and their relationship with bone mineral density".
Piedra M; García-Unzueta MT; Berja A; Paule B; Lavín BA; Valero C; Riancho JA; Amado JA
BMC Med Genet; 2011 Dec; 12():168. PubMed ID: 22185226
[TBL] [Abstract][Full Text] [Related]
17. Polymorphisms in genes in the RANKL/RANK/OPG pathway are associated with bone mineral density at different skeletal sites in post-menopausal women.
Tu P; Duan P; Zhang RS; Xu DB; Wang Y; Wu HP; Liu YH; Si L
Osteoporos Int; 2015 Jan; 26(1):179-85. PubMed ID: 25138264
[TBL] [Abstract][Full Text] [Related]
18. The effects of C161-->T polymorphisms in exon 6 of peroxisome proliferator-activated receptor-gamma gene on bone mineral metabolism and serum osteoprotegerin levels in healthy middle-aged women.
Rhee EJ; Oh KW; Lee WY; Kim SY; Oh ES; Baek KH; Kang MI; Kim SW
Am J Obstet Gynecol; 2005 Apr; 192(4):1087-93. PubMed ID: 15846185
[TBL] [Abstract][Full Text] [Related]
19. Association between g.19163A>G and g.23298T>C genetic variants of the osteoprotegerin gene and bone mineral density in Chinese women.
Liu S; Yi Z; Ling M; Shi J
Hormones (Athens); 2013; 12(4):578-83. PubMed ID: 24457406
[TBL] [Abstract][Full Text] [Related]
20. Association between Wnt signaling pathway gene polymorphisms and bone response to hormone therapy in postmenopausal Korean women.
Kim H; Choe SA; Ku SY; Kim SH; Kim JG
Menopause; 2011 Jul; 18(7):808-13. PubMed ID: 21471826
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
